Danco Laboratories, L.L.C. v. Alliance for Hippocratic Medicine

Linked with:

• Food and Drug Administration v. Alliance for Hippocratic Medicine

Issues: (1) Whether an association can demonstrate Article III standing to enjoin a government action by arguing that some unspecified member may be injured at some future time by the challenged action; and (2) whether the U.S. Court of Appeals for the 5th Circuit erred in upholding the preliminary injunction of the Food and Drug Administration’s 2016 and 2021 actions with respect to mifepristone’s approved conditions of use based on the court’s review of an incomplete administrative record.